Sun Pharma to acquire Innovcare Lifesciences for $28.7 million
Sun Pharmaceutical Industries announced the acquisition of 100% of Innovcare Lifesciences for approximately $28.73 million (2.71 billion rupees).
reuters · 2026-06-20 05:18
2 articles
Sun Pharmaceutical Industries announced the acquisition of 100% of Innovcare Lifesciences for approximately $28.73 million (2.71 billion rupees).
Sun Pharmaceutical Industries agreed to acquire Organon for $11.75 billion, gaining access to its biosimilars portfolio and becoming a top-three global women's health company.